Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: A meta‐analysis of variance
Daniel Martins, Maria Paduraru, Yannis Paloyelis
British Journal of Pharmacology (2021) Vol. 179, Iss. 8, pp. 1525-1543
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

The oxytocin signaling complex reveals a molecular switch for cation dependence
Justin Meyerowitz, Michael J. Robertson, Ximena Barros-Álvarez, et al.
Nature Structural & Molecular Biology (2022) Vol. 29, Iss. 3, pp. 274-281
Closed Access | Times Cited: 39
The effects of oxytocin administration on social and routinized behaviors in autism: A preregistered systematic review and meta-analysis
Kristin Audunsdottir, Alina M. Sartorius, Heemin Kang, et al.
Psychoneuroendocrinology (2024) Vol. 167, pp. 107067-107067
Open Access | Times Cited: 11
Oxytocin—a social peptide? Deconstructing the evidence
Gareth Leng, Rhodri Leng, Mike Ludwig
Philosophical Transactions of the Royal Society B Biological Sciences (2022) Vol. 377, Iss. 1858
Open Access | Times Cited: 37
“Less is more”: A dose-response account of intranasal oxytocin pharmacodynamics in the human brain
Daniel Martins, Katja Brodmann, Mattia Veronese, et al.
Progress in Neurobiology (2022) Vol. 211, pp. 102239-102239
Open Access | Times Cited: 27
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu‐Hua Wu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7092-7092
Open Access | Times Cited: 24
How Do Common Marmosets Maintain the Balance Between Response Execution and Action Inhibition?
Ranshikha Samandra, Marcello G. P. Rosa, Farshad A. Mansouri
American Journal of Primatology (2025) Vol. 87, Iss. 1
Open Access
The neurostructural consequences of glaucoma and their overlap with disorders exhibiting emotional dysregulations: A voxel-based meta-analysis and tripartite system model
Benjamin Klugah‐Brown, Mercy Chepngetich Bore, Xiqin Liu, et al.
Journal of Affective Disorders (2024) Vol. 358, pp. 487-499
Open Access | Times Cited: 4
Role of Oxytocin in Different Neuropsychiatric, Neurodegenerative, and Neurodevelopmental Disorders
Aya A. Ghazy, Omar Soliman, Aya I. Elbahnasi, et al.
Reviews of physiology, biochemistry and pharmacology (2022), pp. 95-134
Closed Access | Times Cited: 18
Two subtypes of schizophrenia identified by an individual-level atypical pattern of tensor-based morphometric measurement
Weiyang Shi, Lingzhong Fan, Haiyan Wang, et al.
Cerebral Cortex (2022) Vol. 33, Iss. 7, pp. 3683-3700
Closed Access | Times Cited: 15
Integrative analysis prioritised oxytocin-related biomarkers associated with the aetiology of autism spectrum disorder
Tao Wang, Tingting Zhao, Liqiu Liu, et al.
EBioMedicine (2022) Vol. 81, pp. 104091-104091
Open Access | Times Cited: 14
Modulation of the thermosensory system by oxytocin
Ugo Zayan, Laura Caccialupi Da Prato, Françoise Muscatelli, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 15
Open Access | Times Cited: 8
Relationship between the domains of theory of mind, social dysfunction, and oxytocin in schizophrenia
Kah Kheng Goh, Mong‐Liang Lu
Journal of Psychiatric Research (2022) Vol. 155, pp. 420-429
Closed Access | Times Cited: 10
The use of intranasal oxytocin in the treatment of eating disorders
Magda Malewska-Kasprzak, Katarzyna Jowik, Marta Tyszkiewicz‐Nwafor
Neuropeptides (2023) Vol. 102, pp. 102387-102387
Open Access | Times Cited: 5
Oxytocin in the Treatment of Psychiatric Disorders
Salim Cagatay KAGIZMAN, Çiçek Hocaoğlu
Medeniyet Medical Journal (2023) Vol. 38, Iss. 3, pp. 218-231
Open Access | Times Cited: 4
Peripartum effects of synthetic oxytocin: The good, the bad, and the unknown
Mahmoud Rashidi, Eduard Maier, Sharon Dekel, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104859-104859
Closed Access | Times Cited: 7
The effects of rehabilitative interventions on reading disorders caused by homonymous visual field defects: a meta-analysis focusing on improvement in reading speed
T Maeyama, Hiroki Okada, Shinya Sakai
Acta Neurologica Belgica (2023) Vol. 124, Iss. 1, pp. 123-140
Closed Access | Times Cited: 3
Building Bridges In Neuropharmacology: New therapeutic approaches for psychiatric and neurodegenerative disorders
Alexis Bailey, Daniel C. Berwick, Rosana Camarini, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 8, pp. 1475-1477
Open Access | Times Cited: 4
Age-dependent effects of oxytocin in brain regions enriched with oxytocin receptors
Shanshan Xiao, Natalie C. Ebner, Amirhossein Manzouri, et al.
Psychoneuroendocrinology (2023) Vol. 160, pp. 106666-106666
Open Access | Times Cited: 2
Deciphering autism heterogeneity: a molecular stratification approach in four mouse models
Lucie P. Pellissier, Caroline Gora, Ana Dudas, et al.
Research Square (Research Square) (2024)
Open Access
Altered projection-specific synaptic remodeling and its modification by oxytocin in an idiopathic autism marmoset model
Jun Noguchi, Satoshi Watanabe, Tomofumi Oga, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
Chronic intranasal oxytocin alleviates cognitive impairment and reverses oxytocin signaling upregulation in MK801-induced mice
Shan Ding, Yong Liu, Huai Tao, et al.
Psychoneuroendocrinology (2024) Vol. 168, pp. 107138-107138
Closed Access
Navigating Central Oxytocin Transport: Known Realms and Uncharted Territories
Deniz Parmaksiz, Yongsoo Kim
The Neuroscientist (2024)
Open Access
Effects of four-week intranasal oxytocin administration on large-scale brain networks in older adults
Peiwei Liu, Tian Lin, Håkan Fischer, et al.
Neuropharmacology (2024) Vol. 260, pp. 110130-110130
Closed Access
Oxytocin reduces noradrenergic-induced opioid-like withdrawal symptoms in individuals on opioid agonist therapy
Brian J. Gully, Zoe E. Brown, Rivkah Hornbacher, et al.
Biological Psychiatry Global Open Science (2024) Vol. 5, Iss. 1, pp. 100395-100395
Open Access
Could intranasal oxytocin enhance the effects of psychotherapy in individuals with mental disorders? A systematic review and meta-analysis
Valeska Pérez-Arqueros, Joaquim Soler, Carlos Schmidt, et al.
Psychoneuroendocrinology (2024) Vol. 171, pp. 107206-107206
Closed Access
Page 1 - Next Page

Scroll to top